-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Navidea Biopharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
- Navidea Biopharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$2.13M, a 57% increase year-over-year.
- Navidea Biopharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$10.2M, a 29.8% increase year-over-year.
- Navidea Biopharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$14.1M, a 16.5% decline from 2021.
- Navidea Biopharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$12.1M, a 12.6% decline from 2020.
- Navidea Biopharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$10.7M, a 2.29% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)